CR Group L.P. - Sep 25, 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
10%+ Owner
Signature
/s/ Nathan D. Hukill, authorized signatory for CRG Partners III L.P., CRG Partners III Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P., and CRG Partners III (Cayman) Lev AIV I L.P.
Stock symbol
TTOO
Transactions as of
Sep 25, 2023
Transactions value $
-$62,500
Form type
4
Date filed
9/27/2023, 05:53 PM
Previous filing
Sep 26, 2023
Next filing
Sep 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Sale -$25K -100K -1.33% $0.25 7.41M Sep 25, 2023 By CRG Partners III L.P. F1
transaction TTOO Common Stock Sale -$15.6K -62.3K -1.33% $0.25 4.61M Sep 25, 2023 By CRG Partners III ? Parallel Fund ?A? L.P. F1
transaction TTOO Common Stock Sale -$5K -20K -1.33% $0.25 1.48M Sep 25, 2023 By CRG Partners III (Cayman) Unlev AIV I L.P. F1
transaction TTOO Common Stock Sale -$16.9K -67.8K -1.33% $0.25 5.02M Sep 25, 2023 By CRG Partners III (Cayman) Lev AIV I L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.